海泰科(301022.SZ):預計未來新能源汽車模具收入會繼續保持增長趨勢
格隆匯5月18日丨海泰科(301022.SZ)5月 17 日召開業績説明會時表示,作為國內外知名整車廠和汽車零部件的供應商,公司獲取訂單的機會較多,更容易被造車新進廠家關注和選擇。目前,公司注塑模具已應用於包括平治、寶馬、大眾、通用、比亞迪、吉利、理想、小鵬、前途、蔚來、Rivian、高合、比亞迪、問界新能源車型,其中公司與比亞迪、吉利採取直接合作的模式。預計未來新能源汽車模具收入會繼續保持增長趨勢。截止 2022 年末,新能源汽車模具收入為 4,382.23 萬元,同比增長49.63%,佔營業收入的 8.76%,同比增長 3.82%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.